Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Trial of Weekly Docetaxel and Daily Temozolomide in Patients With Metastatic Disease

NCT00401180 is registered in ClinicalTrials.gov with The Cleveland Clinic as lead sponsor.

NCT NCT00401180
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00401180 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Trial of Weekly Docetaxel and Daily Temozolomide in Patients With Metastatic Disease
Lead sponsor
The Cleveland Clinic
Phase
Phase 1
Overall status
Completed
Start date
June 30, 2002
Completion date
July 31, 2008
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

unspecified adult solid tumor, protocol specific